| Literature DB >> 24992594 |
Kouki Fujioka1, Sanshiro Hanada2, Yuriko Inoue3, Keisuke Sato4, Kenji Hirakuri5, Kouichi Shiraishi6, Fumihide Kanaya7, Keiichi Ikeda8, Ritsuko Usui9, Kenji Yamamoto10, Seung U Kim11, Yoshinobu Manome12.
Abstract
Several in vivo studies suggest that nanoparticles (smaller than 100 nm) have the ability to reach the brain tissue. Moreover, some nanoparticles can penetrate into the brains of murine fetuses through the placenta by intravenous administration to pregnant mice. However, it is not clear whether the penetrated nanoparticles affect neurogenesis or brain function. To evaluate its effects on neural stem cells, we assayed a human neural stem cell (hNSCs) line exposed in vitro to three types of silica particles (30 nm, 70 nm, and <44 µm) and two types of titanium oxide particles (80 nm and < 44 µm). Our results show that hNSCs aggregated and exhibited abnormal morphology when exposed to the particles at concentrations = 0.1 mg/mL for 7 days. Moreover, all the particles affected the gene expression of Nestin (stem cell marker) and neurofilament heavy polypeptide (NF-H, neuron marker) at 0.1 mg/mL. In contrast, only 30-nm silica particles at 1.0 mg/mL significantly reduced mitochondrial activity. Notably, 30-nm silica particles exhibited acute membrane permeability at concentrations =62.5 µg/mL in 24 h. Although these concentrations are higher than the expected concentrations of nanoparticles in the brain from in vivo experiments in a short period, these thresholds may indicate the potential toxicity of accumulated particles for long-term usage or continuous exposure.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24992594 PMCID: PMC4139811 DOI: 10.3390/ijms150711742
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1(A) SEM images of the particles; (B) size distribution histogram of the particles in Milli-Q water (Mean ± S.D., n = 3); and (C) dispersity in Milli-Q water (1.0 mg/mL).
Physical properties of the dispersed particles in Milli-Q water (supernatant). These data shows mean ± S.D. of two or three measurements.
| Particles | Z-Average in Diameter (nm) | PDI | Zeta Potential |
|---|---|---|---|
|
| 28.5 ± 0.03 | 0.116 ± 0.011 | −26.9 ± 0.2 |
|
| 671.9 ± 13.0 | 0.415 ± 0.028 | −60.6 ± 1.3 |
|
| 1322.7 ± 112.9 | 0.698 ± 0.263 | −35.3 ± 0.3 |
|
| 208.5 ± 4.3 | 0.264 ± 0.030 | −36.2 ± 0.1 |
|
| 210.6 ± 4.7 | 0.223 ± 0.009 | −44.1 ± 1.4 |
Figure 2Observation of hNSCs exposed to particles for 7 days. Orange frames indicate cellular aggregation or morphological abnormalities. (A) Control; (B) FL-SP30; (C) SP70; (D) SPM; (E) TP80; and (F) TPM. In the Figure (B), bright-field images (upper) and fluorescent images (lower) exhibit. Since many FL-SP30 attached to the basement of the plate at 1.0 mg/mL, brightness of the fluorescent images (lower) at 1.0 mg/mL was reduced by 50%. Scale bar (white) indicates 100 μm.
Figure 3Mitochondrial activity during exposure to particles for 7 days. For avoiding the effects of the interaction between particles and the test reagent/culture plates, the mitochondrial activity was calculated in the subtract absorption, “the absorption of co-cultured well (cell + medium + particles)”—“the absorption of no-cell well (medium + particles)”. The results are presented as mean values (n = 3). Error bars represent S.D. The differences between control (0 mg/mL) and particles’ treatments were analyzed with Scheffe’s F test (# p < 0.05; * p < 0.01).
Figure 4Representative images of nuclei (SYTOX Green and Hoechst) and mitochondria (Mitored) of hNSCs exposed to SP30 (0–250 μg/mL for 7 days), (A) Day 1; (B) day 4; and (C) day 7. Observation was conducted with High Content Imaging System Operetta. From the observation images, around 500–4200 cells were analyzed with the Operetta system in each condition (n = 3) (D–F). (D) Ratio of cells stained with SYTOX Green; (E) Average intensity of MitoRed staining; (F) Average intensity of Hoechst 33342 staining; (G) Lactate dehydrogenase (LDH) assay result at day 1 (n = 3). Error bars represent S.D. The differences between control (0 μg/mL) and SP30-treatments were analyzed with Scheffe’s F test (# p < 0.05; * p < 0.01) in each day (D–G). Scale bar (white) indicates 100 μm.
Figure 5Effects of 0.1 mg/mL particles on gene expression of brain cell markers. (A) PCR analyses for differentiation markers (representative data, n = 2); (B) Real-time PCR analyses for HMGA1 expression (n = 2); (C) Effects of FL-SP30 on cellular activity markers in hNSCs (n = 3). The differences between Control and FL-SP30 treatments were analyzed by two-sided Student’s t test (p < 0.05) (C). Error bars represent S.D. The n.s. indicates not significantly different from the Control (p < 0.05).